http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103301506-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_65682d3e437c225d79b93953b4b26392
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-22
filingDate 2013-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d973abf70109d51d20f051a76878905
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec3125285a86d4a8cf5ea7e23bf00a1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6420af360495ecb73aa7d0473303a01c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_823fd21a7dc5269b7d6388e8e90605d9
publicationDate 2015-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103301506-B
titleOfInvention Anticoagulation fibroin membrane and preparation method thereof
abstract The invention discloses an anticoagulation fibroin membrane. The anticoagulation fibroin membrane comprises silk fibroin, hirudin, and an adhesive. The preparation method of the anticoagulation fibroin membrane comprises the following steps of: (1) preparing a silk fibroin solution with the concentration of 4-20%; (2) adding the hirudin and the adhesive into the silk fibroin solution prepared in the step (1) and uniformly mixing to obtain a mixed solution; and (3) curing the mixed solution obtained in the step (2), soaking the cured product in deionized water, and at last taking the soaked product out and air-drying to obtain the anticoagulation fibroin membrane. Compared with the adhesive fibroin membrane without hirudin, the anticoagulation fibroin membrane comprising trace hirudin, disclosed by the invention, has the advantages that the anticoagulation performance is obviously improved, the hirudin and the silk fibroin can form a stable gel network through covalent bonding of amido bonds to exert a long-lasting anticoagulation effect.
priorityDate 2013-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449001107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID442424
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID7091
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16704
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409000855
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84122
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24638
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520385
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID7091
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158220610

Total number of triples: 28.